Vimeo
LinkedIn
Instagram
Share |

stiefel

March 23, 2009

Rumours have been circulating since late last week that Stiefel Laboratories, the family-owned dermatology company, is looking for a buyer.

Rumours have been circulating since late last week that Stiefel Laboratories, the family-owned dermatology company, is looking for a buyer.

Johnson & Johnson, which shares the rights to acne and psoriasis treatments with the US-based company, is one of three drugmakers who have made unsolicited bids along with Novartis and GlaxoSmithKline according to The Wall Street Journal.

Non-listed Stiefel has not commented on the rumours and does not make financial statements, but it is thought the family is seeking around $4 billion.

July 1, 2007

With a production cycle lasting a decade and large conglomerates threatening to swoop, it can be difficult for family-owned pharmaceutical companies to remain both profitable and independent. Andrea Chipman talks to a select few who have made it – Roche, Boehringer, Servier and Stiefel – to learn their strategies for success

Andrea Chipman is a freelance journalist based in the UK.

With a production cycle lasting a decade and large conglomerates threatening to swoop, it can be difficult for family-owned pharmaceutical companies to remain both profitable and independent. Andrea Chipman talks to a select few who have made it – Roche, Boehringer, Servier and Stiefel – to learn their strategies for success

In 2006, the pharmaceutical sector saw another round of consolidation as industry giants gobbled up medium-sized players that had struggled to remain on their own.

Click here >>
Close